Product Information
INGREZZA 40 MG CAPSULE is a brand product labeled by Neurocrine Biosciences, Inc., priced at $258.9417 per EA under NDC 70370204001. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Apr 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Neurocrine Biosciences, Inc.NDC
70370204001
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VALBENAZINE TOSYLATEApproval Type
New Drug (NDA)
FDA Application
NDA209241FDA Approved
4/11/2017
TE Code
AB
On Market Since
12/14/2018
Pharmacological Classes
Price Statistics
The NADAC for INGREZZA 40 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $258.9417 per EA |
|---|---|
| All-time high | $259.0721 (May 13, 2026) |
| All-time low | $240.5638 (Apr 17, 2024) |
| 52-week high | $259.0721 |
| 52-week low | $250.0600 |
| Median price | $250.1433 |
| Average price | $251.1770 |
| Largest weekly change | +3.6% (Oct 8, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Valbenazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INGREZZA 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INGREZZA 40 MG CAPSULE, manufactured by Neurocrine Biosciences, Inc., is $258.9417 per EA (NDC 70370204001), effective Aug 19, 2026.
How has the price of INGREZZA 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for INGREZZA 40 MG CAPSULE has risen 7.6%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for INGREZZA 40 MG CAPSULE?
Since Apr 17, 2024, the NADAC for INGREZZA 40 MG CAPSULE has ranged from a low of $240.5638 (Apr 17, 2024) to a high of $259.0721 (May 13, 2026), with a median of $250.1433 per EA.
Are there cheaper alternatives to INGREZZA 40 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of INGREZZA 40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INGREZZA 40 MG CAPSULE?
INGREZZA 40 MG CAPSULE (NDC 70370204001) is labeled by Neurocrine Biosciences, Inc., and CMS classifies it as a brand product.